Where can I learn more about this trial?
You can find more information about this trial on the websites listed below.
X www.clinicaltrials.gov. Once you are on the website, type “NCT02296918”
into the “Other terms” search box and click “Search”.
X www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“ACE-CL-003” into the search box, and click “Find a Study”.
Full Trial Title: A Phase 1b Study of ACP-196 in Combination with
Obinutuzumab for Patients with Relapsed/Refractory or Untreated CLL/SLL/PLL
Acerta Pharma BV (a member of the AstraZeneca Group of Companies)
Protocol Number: ACE-CL-003
National Clinical Trials Number: NCT02296918
Acerta Pharma BV (a member of the AstraZeneca Group of Companies)
sponsored this study and has its headquarters in Oss, The Netherlands.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical trial participants belong to a large community of people who take
part in clinical research around the world. They help researchers answer
important health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about clinical research participation. CISCRP is not involved
in recruiting participants for clinical trials, nor is it involved in conducting clinical trial.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2022_08_17
16 | Clinical Trial Results